How to Formation is also reduced and inhibited patent retrieval - Eureka

Q: How to Formation is also reduced and inhibited?

Magnolia extract containing compositions,Antibody/drug conjugates and methods of use,Magnolia extract containing compositions,Lytic domain fusion constructs and methods of making and using same,Therapeutic oral composition

Magnolia extract containing compositions

ActiveUS20080260869A1Increase of collagen synthesisIncrease productionCosmetic preparationsBiocideCentella asiatica extractDipeptide

Disclosed is a composition comprising at least two of the following ingredients: Magnolia extract, honokiol, humulus lupulus extract, hesperidin methyl chalcone, gotu kola, dipeptide valyl-tryptophane, palmitoyl tetrapeptide-3, corylus avellana bud extract, centella asiatica extract, cucumis sativa extract, morus alba extract, hibiscus sabdariffa flower extract, vitis vinifera extract, ascorbyl glucoside, citrus medica limonum extract, avena sativa kernel extract, hydrolyzed soy protein, aniseed myrtle extract, tasmania lanceolata leaf extract, artemisia abrotanum extract, or citrus grandis fruit extract or any combination thereof. Also disclosed are methods of treating skin conditions by topically applying the composition to skin.

Magnolia extract containing compositions

View all

Owner:MARY KAY INC

Antibody/drug conjugates and methods of use

ActiveUS20140127241A1Reducing and inhibiting proliferationReducing and inhibiting and growthAntibacterial agentsAntimycoticsDiseaseDrug conjugation

The invention relates to conjugates that bind to targets, methods of using conjugates that bind to targets and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies that express a target.

Antibody/drug conjugates and methods of use

View all

Owner:A28 THERAPEUTICS INC

Magnolia extract containing compositions

ActiveUS7744932B2Increase elasticityImprove firmnessCosmetic preparationsBiocideCentella asiatica extractDipeptide

Disclosed is a composition comprising at least two of the following ingredients: Magnolia extract, honokiol, humulus lupulus extract, hesperidin methyl chalcone, gotu kola, dipeptide valyl-tryptophane, palmitoyl tetrapeptide-3, corylus avellana bud extract, centella asiatica extract, cucumis sativa extract, morus alba extract, hibiscus sabdariffa flower extract, vitis vinifera extract, ascorbyl glucoside, citrus medica limonum extract, avena sativa kernel extract, hydrolyzed soy protein, aniseed myrtle extract, tasmania lanceolata leaf extract, artemisia abrotanum extract, or citrus grandis fruit extract or any combination thereof. Also disclosed are methods of treating skin conditions by topically applying the composition to skin.

View all

Owner:MARY KAY INC

Lytic domain fusion constructs and methods of making and using same

ActiveUS20090269341A1Reducing and inhibiting and growthReducing and inhibiting proliferationNervous disorderFollicle-stimulating hormoneAbnormal tissue growthAberrant cell

The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.

Lytic domain fusion constructs and methods of making and using same

View all

Owner:A28 THERAPEUTICS INC +1

Therapeutic oral composition

ActiveUS9579269B2Ameliorate dry mouthTreat erosion and gingivitisAntibacterial agentsCosmetic preparationsArginineStrontium

Disclosed are therapeutic oral compositions useful in the treatment of a variety of oral disorders, in which the composition can provide blockage of dentinal tubes, while at the same time provide antibacterial and anti-caries efficacy. The compositions include arginine in free or salt form, a mucoadhesive polymer, and at least one component selected from pyrophosphates, zinc salts, potassium salts, strontium salts, and mixtures thereof.

Owner:COLGATE PALMOLIVE CO

Magnolia extract containing compositions

ActiveUS20100143515A1Increase elasticityImprove firmnessCosmetic preparationsBiocideVitis viniferaMedicine

Disclosed is a method of increasing firmness or elasticity or reducing the appearance of sagginess in the periorbital area of a person's skin, comprising topically applying to the skin in need thereof a composition comprising magnolia extract and vitis vinifera extract.

View all

Owner:MARY KAY INC

Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same

InactiveUS20110124564A1Reducing and decreasing and durationReducing and decreasing and and frequencyPeptide/protein ingredientsAntibody mimetics/scaffoldsAntibody conjugateBinding peptide

The invention relates to nucleolin binding peptides, nucleolin binding peptides and anti-nucleolin antibody conjugates with cytotoxic activity, fusion constructs, methods of using nucleolin binding peptides and antibodies and fusion constructs thereof, and methods of treating various disorders, undesirable conditions and diseases treatable with nucleolin binding peptides and fusion constructs, such as undesirable or aberrant cell proliferation (hyperproliferation) or hyperproliferative disorders, including tumors, cancers, neoplasia and malignancies, angiogenesis related or dependent diseases, and inflammatory diseases and inflammation.

Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same

View all

Owner:A28 THERAPEUTICS INC

Lytic domain fusion constructs and methods of making and using same

ActiveUS8318899B2Reducing and inhibiting and growthReducing and inhibiting proliferationNervous disorderPeptide/protein ingredientsAbnormal tissue growthAberrant cell

The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.

View all

Owner:A28 THERAPEUTICS INC +1

Photoresist processing aid and method

InactiveUS6900003B2Reduce the amount requiredFormation is also reduced and inhibitedOrganic detergent compounding agentsPhotoprinting processesProcessing aidAntifoam agent

A composition and method to reduce photolithographic residue and scum formation on a substrate or in a solution, and to reduce or prevent foam formation. The composition contains a diphenyl oxide compound in combination with an antifoam agent. The composition may be added to developer solutions and stripper solutions used in manufacturing printed wiring boards.

View all

Owner:SHIPLEY CO LLC

Method of demulsing a natural gas dehydrator

ActiveUS20080081773A1Eliminate accumulationFormation is also reduced and inhibitedGaseous fuelsIsotope separationDemulsifierNatural gas dehydration

Provided is a method of inhibiting the formation of emulsions in a natural gas dehydrator by lubricating the upstream compressors and natural gas engines with a lubricating oil comprising an effective amount of one or more demulsifiers. Provided is also a method of lubricating the upstream compressors and natural gas engines with the same oil compositions.

Owner:CHEVRON ORONITE CO LLC

Filling through-holes

InactiveUS20160105975A1Reduce and inhibit dimple formationReduce and inhibit and voidAnodisationPrinted circuit aspectsCopperPulse plating

Pulse plating methods which include a forward pulse but no reverse pulse inhibit or reduce dimpling and voids during copper electroplating of through-holes in substrates such as printed circuit boards. The pulse plating methods may be used to fill through-holes with copper where the through-holes are coated with electroless copper or flash copper.

View all

Owner:ROHM & HAAS ELECTRONICS MATERIALS LLC

Method of filling through-holes

InactiveUS20140262801A1Reduce and inhibit dimple formationReduce and inhibit and voidLiquid/solution decomposition chemical coatingPrinted circuit manufactureCopperElectroplating

The methods inhibit or reduce dimpling and voids during copper electroplating of through-holes with flash copper layers in substrates such as printed circuit boards. An acid solution containing disulfide compounds is applied to the through-holes of the substrate followed by filling the through-holes with copper using an acid copper electroplating bath which includes additives such as brighteners and levelers.

View all

Owner:ROHM & HAAS ELECTRONICS MATERIALS LLC

Method of filling through-holes to reduce voids and other defects

ActiveUS20170238427A1Reduce and inhibit dimple formationReduce and inhibit and voidPrinted circuit aspectsLiquid/solution decomposition chemical coatingHigh current densityPower flow

Direct current plating methods inhibit void formation, reduce dimples and eliminate nodules. The method involves electroplating copper at a high current density followed by electroplating at a lower current density to fill through-holes.

Method of filling through-holes to reduce voids and other defects

View all

Owner:ROHM & HAAS ELECTRONICS MATERIALS LLC

Lytic domain fusion constructs and methods of making and using same

InactiveUS20090233860A1Reducing and inhibiting and growthReducing and inhibiting proliferationNervous disorderPeptide/protein ingredientsAbnormal tissue growthAberrant cell

The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.

View all

Owner:BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV & AGRI & MECHANICAL COLLEGE +1

Proteinaceous molecules and uses therefor

PendingUS20200339691A1Nuclear localization is improvedInhibiting and reducingPeptide/protein ingredientsImmunoglobulins against cell receptors/antigens/surface-determinantsProtein moleculesAcetylation

Disclosed are proteinaceous molecules corresponding to an acetylation site and their use for inhibiting or reducing the nuclear localization of a nuclear localizable polypeptide, such as PD-1, PD-L1 and PD-L2. This invention also relates to the use of the proteinaceous molecules for altering at least one of (i) formation; (ii) proliferation; (iii) maintenance; (iv) epithelial to mesenchymal cell transition (EMT); or (v) mesenchymal to epithelial cell transition (MET) of a PD-1-, PD-L1- or PD-L2-overexpressing cell, and for treating or preventing a cancer in a subject.

Proteinaceous molecules and uses therefor

View all

Owner:EPIAXIS THERAPEUTICS PTY LTD

Method of filling through-holes

InactiveUS20140262799A1Reduce and inhibit dimple formationReduce and inhibit and voidLiquid/solution decomposition chemical coatingPrinted circuit manufactureNitrogenCopper

The methods inhibit or reduce dimpling and voids during copper electroplating of through-holes with flash copper layers in substrates such as printed circuit boards. An acid solution containing reaction products of aromatic heterocyclic nitrogen compounds and epoxy-containing compounds is applied to the through-holes of the substrate followed by filling the through-holes with copper using a copper electroplating bath which includes additives such as brighteners and levelers.

View all

Owner:ROHM & HAAS ELECTRONICS MATERIALS LLC

Method of demulsing a natural gas dehydrator

ActiveUS8163680B2Eliminate accumulationFormation is also reduced and inhibitedGaseous fuelsIsotope separationDemulsifierNatural gas dehydration

Provided is a method of inhibiting the formation of emulsions in a natural gas dehydrator by lubricating the upstream compressors and natural gas engines with a lubricating oil comprising an effective amount of one or more demulsifiers. Provided is also a method of lubricating the upstream compressors and natural gas engines with the same oil compositions.

Owner:CHEVRON ORONITE CO LLC

Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use

ActiveUS9586996B2Reducing and inhibiting and growthReducing and inhibiting proliferationSugar derivativesImmunoglobulins against cell receptors/antigens/surface-determinantsLytic peptideDisease

The invention relates to conjugates that bind to Her2 / neu, methods of using conjugates that bind to Her2 / neu and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies that express Her2 / neu.

Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use

View all

Owner:A28 THERAPEUTICS INC

Texturing of monocrystalline semiconductor substrates to reduce incident light reflectance

ActiveUS20140065836A1Improve efficiencyFormation be also reduce and inhibitBiocideOrganic chemistryChemistrySingle crystal

Monocrystalline semiconductor substrates are textured with alkaline solutions to form pyramid structures on their surfaces to reduce incident light reflectance and improve light absorption of the wafers. The alkaline baths include hydantoin compounds and derivatives thereof in combination with alkoxylated glycols to inhibit the formation of flat areas between pyramid structures to improve the light absorption.

Texturing of monocrystalline semiconductor substrates to reduce incident light reflectance

View all

Owner:SUN CHEM CORP

Therapeutic oral composition

ActiveUS20170128340A1Ameliorate dry mouthTreat erosion and gingivitisAntibacterial agentsCosmetic preparationsDiseaseArginine

Disclosed are therapeutic oral compositions useful in the treatment of a variety of oral disorders, in which the composition can provide blockage of dentinal tubes, while at the same time provide antibacterial and anti-caries efficacy. The compositions include arginine in free or salt form, a mucoadhesive polymer, and at least one component selected from pyrophosphates, zinc salts, potassium salts, strontium salts, and mixtures thereof.

Owner:COLGATE PALMOLIVE CO

Cosmetic and dermatological formulations of MNTF peptides

ActiveUS8334253B2Good lookingReduce harmCosmetic preparationsPeptide/protein ingredientsDermatologyPeptide

The disclosure is directed to methods and compositions that include MNTF peptides and their analogs for cosmetic and dermatological purposes.

Cosmetic and dermatological formulations of MNTF peptides

View all

Owner:DERMACARE NEUROSCI INST

Antibody/drug conjugates and methods of use

ActiveUS20170121370A1Reducing and inhibiting proliferation and growthReducing and inhibiting cell proliferationAntibacterial agentsAntimycoticsDrug conjugationMalignancy

The invention relates to conjugates that bind to targets, methods of using conjugates that bind to targets and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies that express a target.

View all

Owner:A28 THERAPEUTICS INC

Compositions And Methods For Inhibiting Drusen

InactiveUS20150051212A1Reduce and inhibt drusen formationAmeliorate and prevent and inhibit drusen-associated disorderBiocideAntinoxious agentsDrusenCancer research

Described herein are methods for inhibiting drusen.

Compositions And Methods For Inhibiting Drusen

View all

Owner:REGENERATIVE RES FOUND

Method of filling through-holes to reduce voids and other defects

ActiveUS20170233886A1Reduce and inhibit dimple formationReduce and inhibit and voidCellsLiquid/solution decomposition chemical coatingHigh current densityCopper

Direct current plating methods inhibit void formation, reduce dimples and eliminate nodules. The method involves electroplating copper at a high current density followed by a pause in electroplating and then turning on the current to electroplate at a lower current density to fill through-holes.

View all

Owner:ROHM & HAAS ELECTRONICS MATERIALS LLC

Method of filling through-holes

InactiveUS9598787B2Formation is also reduced and inhibitedImprove throwing powerLiquid/solution decomposition chemical coatingPrinted element electric connection formationNitrogenCopper

The methods inhibit or reduce dimpling and voids during copper electroplating of through-holes with flash copper layers in substrates such as printed circuit boards. An acid solution containing reaction products of aromatic heterocyclic nitrogen compounds and epoxy-containing compounds is applied to the through-holes of the substrate followed by filling the through-holes with copper using a copper electroplating bath which includes additives such as brighteners and levelers.

View all

Owner:ROHM & HAAS ELECTRONICS MATERIALS LLC

Texturing of monocrystalline semiconductor substrates to reduce incident light reflectance

InactiveUS20140004701A1Low oxygenIncrease incident light absorptionAfter-treatment detailsSemiconductor/solid-state device manufacturingSingle crystalLight reflectance

Monocrystalline semiconductor substrates are textured with alkaline solutions to form pyramid structures on their surfaces to reduce incident light reflectance and improve light absorption of the wafers. The alkaline baths include compounds which inhibit the formation of flat areas between pyramid structures to improve the light adsorption.

View all

Owner:SUN CHEM CORP

Intraocular lens with a proofed surface

ActiveUS20140228947A1Formation of spots inside the polymer matrix is inhibited or reducedAvoid paddingOptical articlesIntraocular lensIntraocular lensMedicine

Methods and apparatus for an intraocular lens with a proofed surface are disclosed. The proofed surface functions as a barrier to fluid diffusion inside the material and within vacuoles. By preventing the interstitial filling of fluid, the formation of spots inside the polymer matrix is inhibited or reduced. The proofed surface of the intraocular lenses is a highly stable re-assembled surface without any coating or grafting.

View all

Owner:S I F I SPA

Method of filling through-holes to reduce voids and other defects

ActiveUS10512174B2Formation is also reduced and inhibitedImprove throwing powerPrinted circuit aspectsLiquid/solution decomposition chemical coatingHigh current densityCopper

Direct current plating methods inhibit void formation, reduce dimples and eliminate nodules. The method involves electroplating copper at a high current density followed by electroplating at a lower current density to fill through-holes.

View all

Owner:ROHM & HAAS ELECTRONICS MATERIALS LLC

Compositions and methods for reduction of lipoprotein a formation and treatment of aortic valve sclerosis and aortic stenosis

PendingUS20210155682A1Reducing and inhibiting formationReduce severityCompound screeningApoptosis detectionAntigenUrology

Compositions and methods to reduce the formation of lipoprotein(a) are provided, thereby reducing the risk of aortic stenosis or aortic valve sclerosis. Antibodies or antigen-binding fragments thereof capable of binding apolipoprotein B100 or apolipoprotein a are provided, which effectively prevents the binding and assembly of lipoprotein(a), thereby reducing the risk of aortic valve stenosis or sclerosis.